GW4064 10mg 10mg | Purity Not Available
Adooq Bioscience
GW4064 is a selective, non-steroidal farnesoid X receptor (FXR) agonist (EC50 = 15 nM).
More Information Supplier PageGW4064 is a selective, non-steroidal farnesoid X receptor (FXR) agonist (EC50 = 15 nM).
More Information Supplier PageNPS-2143 is a selective Ca2+-sensing receptor antagonist, shown to block increases in cytoplasmic Ca2+ concentrations elicited by human Ca2+ receptors expressed in HEK293 cells with an IC50 of 43 nM.
More Information Supplier PageNPS-2143 is a selective Ca2+-sensing receptor antagonist, shown to block increases in cytoplasmic Ca2+ concentrations elicited by human Ca2+ receptors expressed in HEK293 cells with an IC50 of 43 nM.
More Information Supplier PagePF 431396 is a dual focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2) inhibitor (IC50 values are 2 and 11 nM respectively).
More Information Supplier PagePF 431396 is a dual focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2) inhibitor (IC50 values are 2 and 11 nM respectively).
More Information Supplier PageTH-302 is a selectively targeting hypoxic regions of solid tumors hypoxia-activated prodrug.
More Information Supplier PageTH-302 is a selectively targeting hypoxic regions of solid tumors hypoxia-activated prodrug.
More Information Supplier PageTH-302 is a selectively targeting hypoxic regions of solid tumors hypoxia-activated prodrug.
More Information Supplier PageSB-705498 is a potent, selective and orally bioavailable TRPV1 antagonist.
More Information Supplier PageSB-705498 is a potent, selective and orally bioavailable TRPV1 antagonist.
More Information Supplier Page